Study on the Effects and Mechanisms of Sea Buckthorn Fruit Pulp in Improving Polycystic Ovary Syndrome
Abstract
Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder characterized by ovarian dysfunction, hyperandrogenism, and insulin resistance. This study investigated the therapeutic effects and potential mechanisms of sea buckthorn pulp (Pu; Hippophae rhamnoides fruit pulp) in a letrozole-induced PCOS mouse model. PCOS-like mice were established by letrozole administration combined with a high-fat diet and subsequently treated with Pu or metformin for 39 days. Body weight, glucose metabolism, estrous cyclicity, ovarian histopathology, and serum hormone levels were evaluated. Network pharmacology and Western blot analyses were performed to explore the potential molecular mechanisms. Pu treatment significantly reduced body weight gain and improved glucose tolerance and insulin sensitivity in PCOS mice (p p < 0.05). Pu treatment was also associated with increased ovarian expression of p-PI3K and p-mTOR. These findings suggest that sea buckthorn pulp ameliorates reproductive and metabolic dysfunction in PCOS mice, and its therapeutic effects may be associated with modulation of the PI3K/AKT/mTOR signaling pathway. Further studies are warranted to confirm the underlying mechanisms and evaluate its translational potential in clinical settings.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.